Crew Capital Management’s Gilead Sciences GILD Stock Holding History

Crew Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$293K	Sell	2,099 -473	-18%	-$66.2K	0.19%	91
2025 Q4	$316K	Hold	2,572	–	–	0.2%	87
2025 Q3	$285K	Hold	2,572	–	–	0.19%	92
2025 Q2	$285K	Sell	2,572 -4,509	-64%	-$480K	0.2%	96
2025 Q1	$793K	Sell	7,081 -259	-4%	-$26.7K	0.65%	60
2024 Q4	$678K	Sell	7,340 -6,479	-47%	-$583K	0.56%	65
2024 Q3	$1.16M	Buy	+13,819	New	+$1.05M	0.93%	23
2024 Q1	–	Sell	-4,913	Closed	-$398K	–	123
2023 Q4	$398K	Buy	4,913 +954	+24%	+$74.2K	0.41%	50
2023 Q3	$297K	Buy	3,959 +11	+0.3%	+$846	0.32%	58
2023 Q2	$304K	Hold	3,948	–	–	0.35%	63
2023 Q1	$328K	Hold	3,948	–	–	0.47%	55
2022 Q4	$339K	Hold	3,948	–	–	0.49%	53
2022 Q3	$244K	Hold	3,948	–	–	0.33%	78
2022 Q2	$244K	Hold	3,948	–	–	0.31%	81
2022 Q1	$235K	Hold	3,948	–	–	0.23%	93
2021 Q4	$287K	Hold	3,948	–	–	0.24%	87
2021 Q3	$276K	Hold	3,948	–	–	0.26%	83
2021 Q2	$272K	Hold	3,948	–	–	0.25%	84
2021 Q1	$255K	Buy	+3,948	New	+$255K	0.25%	88

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Crew Capital Management's GILD Position: Q1 2026 in Review

Crew Capital Management reduced its Gilead Sciences (GILD) stake by 18% in Q1 2026, selling an estimated $66.2K and leaving 2,099 shares worth $293K. The position accounts for 0.19% of the portfolio, ranked #91.

Crew Capital Management first reported a position in GILD in Q1 2021 and has held it in 19 quarters since. The position peaked at $1.16M in Q3 2024. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Crew Capital Management held 2,099 shares of Gilead Sciences worth $293K as of Q1 2026.
Crew Capital Management sold 473 Gilead Sciences shares in Q1 2026, an estimated $66.2K.
Gilead Sciences made up 0.19% of Crew Capital Management's portfolio in Q1 2026, its #91 holding.
Crew Capital Management first reported a position in Gilead Sciences in Q1 2021 and has held it in 19 quarters since.
Crew Capital Management's Gilead Sciences position peaked at $1.16M in Q3 2024.
2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Crew Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.